PE-22-28 is a laboratory-made seven-amino-acid peptide, sold as a research chemical, built to block a potassium channel that keeps nerve cells quiet, with mood as the intended target. Everything known comes from cells and mice; no study in people has been published or registered, and no safety work exists in any species. It stands as a laboratory hypothesis rather than a usable one. (Full Review)
| Marker | Target | Why |
|---|---|---|
| Resting heart rate and rhythm (electrocardiogram) | 60–100 beats per minute | Safety check: new bradycardia or sinus pause would stop use |
| Fasting plasma glucose | 70–99 mg/dL | Safety check: hypoglycemia would stop use |
| Glycated hemoglobin (HbA1c) | 4.0–5.6% | Marker the intervention is expected to change, in either direction |
| Structured depression score (e.g., PHQ-9) | No established target — track change from the individual's own baseline | Marker the intervention is expected to change: mood is the claimed effect |
Cadence: No cadence rests on evidence; baseline before any use, then the rhythm and glucose measures at 1 week and 4 weeks and the mood score weekly, with any new bradycardia, pause, seizure, hypoglycemia or neurological symptom treated as a reason to stop